Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Japanese patients

Pediatrics International

Volumn 39, Issue 5, 1997, Pages 584-589

  Saitoh, Makiko ^a   Sakakihara, Yoichi ^a   Kobayashi, Shigetoshi ^a   Hayashi, Yasuhide ^a   Yanagisawa, Masayoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

NAIP; SMA; SMN

Indexed keywords

ADOLESCENT; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENOTYPE; HUMAN; HYPOTHESIS; INFANT; MALE; NEWBORN; PRIORITY JOURNAL; SCHOOL CHILD; SPINAL MUSCULAR ATROPHY; SYMPTOMATOLOGY;

ASIAN CONTINENTAL ANCESTRY GROUP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EXONS; FEMALE; GENE DELETION; HOMOZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MUSCULAR DYSTROPHIES; NERVE TISSUE PROTEINS; NEURONAL APOPTOSIS-INHIBITORY PROTEIN; RNA-BINDING PROTEINS;

EID: 0030882648     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1997.tb03645.x     Document Type: Article

References (28)

1. Munsat TM, Davies KE. Meeting report: International SMA Consortium Meeting. Neuromusc. Dis. 1992; 2: 423–8.
2. Zerres K., Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy (SMA) — clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch. Neurol. 1995; 52: 518–23.
3. Pearn J. Classification of spinal muscular atrophies. Lancet 1980; ii, 919–22.
4. Brzustowicz LM, Lehner T., Castilla LH et al. Genetic mapping of chronic childhood-onset spinal atrophy to chromosome 5q11.2–13.3. Nature 1990; 344: 540–1.
5. Merki J., Abdelhak S., Sheth P. et al. Gene for chronic proximal spinal muscular atrophies maps to chromosomes 5q Nature 1990; 344: 767–8.
6. Gilliam T., Brzustowicz LM, Castilla LH et al. Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Nature 1990; 345: 823–5.
7. Merki J., Sheth P., Abdelhak S. et al. Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12–q14. Lancet 1990; 336: 271–3.
8. Wirth B., El-Agwany A., Baasner A. et al. Mapping of the spinal muscular atrophy (SMA) gene to a 750kb interval flanked by two new microsatellites. Eur. J. Hum. Genet. 1995. 3: 56–60.
9. Lefebvre S., Burglen L., Reboullet S. et al. Identification and characterization of the spinal muscular atrophy determining gene. Cell 1995; 80: 155–65.
10. Roy N., Mahadevan M., McLean M. et al. The gene for neuronal apoptosis inhibitory protein (NAIP), a novel protein with homology to baculoviral inhibitor of apoptosis, is partially deleted in individuals with type I spinal muscular atrophy (SMA). Cell 1995; 80: 167–78.
11. Thompson TG, Didonato CJ, Simard RL et al. Novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients. Nature Genet. 1995; 9: 56–62.
12. Crawford TO. From enigmatic to problematic: The new molecular genetics of childhood spinal muscular atrophy. Neurology 1996; 46: 335–40.
13. Sakakihara Y., Kubota M., Kim S. Attitude of physicians towards life-sustaining treatment for Werdnig-Hoffmann disease. Acta Pediatr. Japon. 1996; 38: 137–42.
14. Komuro H., Hayashi Y., Kawamura M. et al. Mutations of p53 gene involved in Ewing's sarcoma but not in neuroblastoma. Cancer Res. 1993; 53: 5284–8.
15. Kawamura M., Kikuchi A., Kobayashi S. et al. Mutations of p53 gene and ras genes in childhood t(1:19)-acute lymphoblastic leukemia. Blood 1995; 85: 2546–52.
16. Van der Steege G., Grootscholten PM, Van der Vlies P. et al. PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 1995; 345: 985–6.
17. Oka A., Matsushita Y., Sakakihara Y. et al. Spinal muscular atrophy with oculomotor palsy, epilepsy and cerebellar hypoperfusion. Pediatr. Neurol. 1995; 12: 365–9.
18. Wirth B., Hahnen E., Morgan K. et al. Allelic association and deletions in autosomal recessive proximal spinal muscular atrophy: Association of marker genotype with disease severity and candidate gene. Hum. Mol. Genet. 1995; 4: 1273–84.
19. Hahnen E., Forkert R., Marke C. et al. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum. Mol. Genet. 1995; 4: 1927–33.
20. Capon F., Levato C., Semprini S. et al. Deletion analysis of SMN and NAIP genes in spinal muscular atrophy Italian families. Muscle Nerve 1996; 19: 378–80.
21. Burlet P., Burglen L., Clermont O. et al. Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease. J. Med. Genet. 1996; 33: 281–3.
22. Spiegel R., Hagmann A., Boltshauser E. et al. Molekulargenetische Dianose und Deletionsanalyse bei spinaler Muskelatrophie Typ I-III. Schweiz. Med. Wochensch. 1996; 126: 907–14.
23. Ishikawa Y., Ishikaw Y., Minami R. Mutation of SMN and NAIP in childfood-onset spinal muscular atrophy, (in Jpn.) No-To-Hattatsu 1996; 28; 450–3.
24. Rodrigues NR, Owen N., Talbot K. et al. Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum. Mol. Genet. 1995; 4: 631–4.
25. Lewin B. Genes for SMA: Multum in parvo. Cell 1995; 80: 1–5.
26. Parano E., Pavone L., Falsaperla R. et al. Molecular basis of phenotypic heterogeneity in siblings with spinal muscular atrophy. Ann. Neurol. 1996; 40: 247–51.
27. Rudnik-Schoneborn S., Forkert R., Hahnen E. et al. Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletion findings. Neuropediatr. 1996; 27: 8–15.
28. Cobben JM, Van der Steege G., Grootscholoten P. et al. Deletions of the survival motor neuron gene (SMN) in unaffected siblings of patients with spinal muscular atrophy. Am. J. Hum. Genet. 1995; 57: 805–8.